Two stocks in Healthcare
Regeneron Pharmaceuticals vs Thermo Fisher Scientific: profit, growth, debt and price compared
Regeneron Pharmaceuticals is stronger on 6 of 7 figures: profit margin, sales growth, debt, price for its expected profit, dividend and price trend. Thermo Fisher Scientific is stronger on 1: analysts' view.
Save both stocks to your watchlist and revisit their latest fundamentals.
| Regeneron PharmaceuticalsREGN | Thermo Fisher ScientificTMO | |
|---|---|---|
| Net margin | Stronger: 28.5% | 14.9% |
| Revenue growth, past year | Stronger: +36.27% | +9.13% |
| Debt to equity | Stronger: 8.1% | 75.4% |
| Forward P/E | Stronger: 13.3× | 24.9× |
| Dividend yield | Stronger: 0.39% | 0.27% |
| Analysts | Buy · 27 | Stronger: Strong buy · 25 |
| From its 200-day average | Stronger: +24.2% | +17.3% |
Share price over the past year
- Regeneron Pharmaceuticals+30.4%
- Thermo Fisher Scientific+20.3%
18 Nov 202518 Nov 2026
Regeneron Pharmaceuticals or Thermo Fisher Scientific: which is stronger?
- REGN
Which is more profitable?
Regeneron Pharmaceuticals keeps more of each sale as profit: 28.5% against 14.9%.
- REGN
Which is growing its sales faster?
Regeneron Pharmaceuticals is growing its sales faster: +36.27% over the past year, against +9.13%.
- REGN
Which has borrowed less?
Regeneron Pharmaceuticals has borrowed less: its debt is 8.1% of what its shareholders own, against 75.4% for Thermo Fisher Scientific.
- REGN
Which costs less for the profit it is expected to make?
Regeneron Pharmaceuticals costs less for the profit it is expected to make: 13.3× its forward earnings, against 24.9×.
- REGN
Which pays more in dividends?
Regeneron Pharmaceuticals pays more back in dividends for what a share costs: 0.39% a year, against 0.27%.
- TMO
Which do analysts rate higher?
Analysts are warmer on Thermo Fisher Scientific: Strong buy, against Buy for Regeneron Pharmaceuticals.
- REGN
Which is in the stronger price trend?
Regeneron Pharmaceuticals' price is in the stronger trend: 24.2% above its 200-day average, against 17.3% above.
What each company does
REGNRegeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
Reports results on 28 January 2027
TMOThermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.
Reports results on 28 January 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.